• Streptavidin-HyperFluor 647: A Smarter Assay Map

  2026-08-24

  Streptavidin-HyperFluor 647 connects biotin labeling chemistry to sensitive red-fluorescence readouts. This guide explains when a Streptavidin fluorescent conjugate is preferable to biotin-free click-compatible strategies and how to design interpretable microscopy, flow, and FRET assays.

• IWR-1-endo Workflow for Wnt Signaling Research

  2026-08-24

  IWR-1-endo provides a practical way to suppress Wnt/β-catenin activity in colorectal cancer, stem-cell, zebrafish, and image-based phenotyping workflows. This guide connects Axin-complex biology with reproducible dosing, morphology profiling, controls, and troubleshooting while clarifying how the CARDIO study can inform assay design without overstating its findings.

• Azathramycin A: A Smarter TB Assay Framework

  2026-08-23

  Azathramycin A is a macrolide antibiotic for mechanistic tuberculosis research, with ribosome-focused activity and useful stress-degradation characteristics. This guide develops a matrix-aware assay framework that connects target engagement, infection-model design, and antibiotic resistance research without overstating evidence across species.

• Deferasirox and the Iron Logic of Ferroptosis

  2026-08-22

  Deferasirox is an oral iron chelator with established value in transfusional iron overload and emerging utility as a mechanistic probe for tumor iron biology. This article connects its iron-binding, mitochondrial ROS, and myeloid effects with the METTL16–SENP3–LTF ferroptosis-resistance axis in hepatocellular carcinoma, while outlining experiments that separate iron depletion from lysosomal, apoptotic, and ferroptotic stress.

• Cepharanthine Suppresses Endometriosis Growth

  2026-08-21

  This 2026 reference study evaluates Cepharanthine across stromal-cell assays, patient-derived endometrial organoids, and a mouse model, linking lesion suppression to G0/G1 arrest, DNA damage, impaired repair, and apoptosis. Its multi-model design provides a useful preclinical framework for testing a biscoclaurine alkaloid in endometriosis while also clarifying the evidence gaps before clinical translation.

• Prochlorperazine-Induced Neuroleptic Malignant Syndrome

  2026-08-20

  This case report highlights neuroleptic malignant syndrome after standard-dose prochlorperazine in an older patient whose presentation was clinically characteristic despite limited laboratory abnormalities. It supports medication-history review, neurological examination, and early benzodiazepine-based management when conventional biochemical findings are absent.

• 10074-G5: A Mechanistic Guide to c-Myc Biology

  2026-08-20

  10074-G5 is a c-Myc inhibitor that helps dissect how MYC/Max signaling connects oncogenic growth with apoptosis, cell-cycle control, and epithelial-to-mesenchymal transition. This guide interprets the compound alongside recent MYC/TERT/NFκB findings and translates them into better assay decisions.

• Gly-Gly-Phe-Gly (GGFG) in Bioconjugation

  2026-08-19

  Gly-Gly-Phe-Gly (GGFG) is a compact, flexible spacer for testing drug-conjugate geometry, peptide architectures, and biomaterial interfaces. This research-focused guide connects practical linker workflows with mechanistic assay lessons from panobinostat studies in MLL-rearranged leukemia, while clearly separating established evidence from prospective applications.

• ST3GAL1, Sialylation, and F. nucleatum Adhesion

  2026-08-19

  A recent study identifies ST3GAL1-driven sialylation as a host determinant of Fusobacterium nucleatum adhesion to colorectal cancer cells and links persistent colonization to the H3K27ac/ANGPTL4 axis. The work connects tumor-associated glycan remodeling with bacterial retention and provides a framework for evaluating adhesion, colonization, and downstream tumor-promoting effects separately.

• Potassium Iodide Workflows for Thyroid Research

  2026-08-18

  Potassium Iodide provides a simple, water-soluble iodide source for controlled thyroid uptake, thyroid hormone synthesis, and radioactive iodine thyroid blocking experiments. This guide combines practical KI handling with a staged assay mindset inspired by an MMP-2-responsive immunotherapy study, while clearly separating established product properties from exploratory recommendations.

• OSMI-1: Reliable O-GlcNAc Assay Design

  2026-08-18

  Learn how OSMI-1 (SKU B7923) can support controlled OGT inhibition, target-engagement studies, and interpretation of viability or cytotoxicity data. This scenario-based guide covers dosing, DMSO compatibility, assay controls, cross-domain limitations, and practical product-selection criteria.

• Streptavidin-FITC Workflows for Biotin Detection

  2026-08-17

  Streptavidin-FITC converts biotinylated antibodies, nucleic acids, and nanoparticles into a flexible FITC imaging or flow-cytometry readout. This guide connects routine staining with an advanced lipid nanoparticle trafficking workflow, emphasizing controls, assay design, and practical troubleshooting.

• Grazoprevir Hydrate: HCV Research Workflows

  2026-08-17

  Build genotype-aware HCV replication assays around a potent NS3/4A protease inhibitor, then extend them to combination, resistance, and translational studies. This workflow emphasizes practical dilution design, orthogonal readouts, and troubleshooting for picomolar-range activity.

• YTHDF1 Phase Separation in SSC Fate Transition

  2026-08-16

  The Cell Reports study identifies YTHDF1 liquid-liquid phase separation as a mechanistic driver of spermatogonial stem cell transdifferentiation into neural stem cell-like cells. Its perturbation and rescue experiments connect m6A-dependent RNA handling to the IκB-NF-κB-CCND1 axis, providing a framework for studying protein-RNA condensates in cell-fate control.

• Asymmetric Suzuki Synthesis of an Antimitotic Biaryl

  2026-08-15

  Herrbach and co-workers reported a catalytic atropo-enantioselective Suzuki coupling to access an axially chiral biaryl precursor of the antimitotic rhazinilam analogue (-)-2. Ligand screening identified binaphthyl phosphine 7a as an effective and comparatively versatile ligand, although the reported enantioselectivity reached only 40% ee, highlighting both the conceptual advance and the remaining optimization challenge.

8589 records 1/573 page Next 12345 下5页 Last page